Published on: June 10, 2016

GlaxoSmithKline LLC et al. v. Glenmark Pharmaceuticals Inc., USA, et al., C.A. Nos. 14-877, 14-878-LPS-CJB (D. Del. June 3, 2016).

Revised Local Rules (Civil) Effective August 1, 2016

The District of Delaware’s revised Local Rules for civil cases will take effect August 1, 2016. A copy of the revised Local Rules is linked below. District of Delaware LOCAL RULES 2016

Jury Returns $393.6 Million Verdict In Favor of Edwards Lifesciences

We previously reported on Judge Sleet’s in limine rulings directed to Section 271(f) and European Patent Office proceedings in patent litigation related to aortic valve stents between Edwards Lifesciences and Medtronic Corevalve. After a jury trial last week, the jury awarded Edwards Lifesciences lost profit damages and reasonable royalties. The verdict form has been made […]

Delaware IP Law Bloggers Comment on Supreme Court’s Myriad Decision

Delaware IP Law Blog Author, Greg Brodzik, and Contributor, Jim Lennon, were invited by IPWatchdog.com to comment on the Supreme Court’s recent decision in Association for Molecular Pathology, et al. v. Myriad Genetics, Inc., et al., 569 U.S. ___, on the scope of patent eligibility in the context of DNA discoveries. Follow this link to […]